Patricia Shaw
University Health Network
124 Papers
460 Citations
Patricia Shaw is an academic researcher from University Health Network. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 43, co-authored 119 publications. Previous affiliations of Patricia Shaw include Princess Margaret Cancer Centre & University of Pittsburgh.
Chat about Author
Papers
International network of cancer genome projects
Thomas J. Hudson,Thomas J. Hudson,Warwick Anderson,Axel Aretz,Anna D. Barker,Cindy Bell,Rosa R. Bernabé,Maharaj K. Bhan,Fabien Calvo,Iiro Eerola,Daniela S. Gerhard,Alan E. Guttmacher,Mark S. Guyer,Fiona M. Hemsley,Jennifer L. Jennings,David J. Kerr,Peter Klatt,Patrik Kolar,Jun Kusuda,David P. Lane,Frank Laplace,Youyong Lu,Gerd Nettekoven,Brad Ozenberger,Jane Peterson,T. S. Rao,Jacques Remacle,Alan J. Schafer,Tatsuhiro Shibata,Michael R. Stratton,Joseph G. Vockley,Koichi Watanabe,Huanming Yang,Matthew Ming Fai Yuen,Bartha Maria Knoppers,Martin Bobrow,Anne Cambon-Thomsen,Lynn G. Dressler,Stephanie O.M. Dyke,Yann Joly,Kazuto Kato,Karen Kennedy,Pilar Nicolás,Michael Parker,Emmanuelle Rial-Sebbag,Carlos M. Romeo-Casabona,Kenna M. Shaw,Susan E. Wallace,Georgia L. Wiesner,Nikolajs Zeps,Peter Lichter,Andrew V. Biankin,Andrew V. Biankin,Christian Chabannon,Lynda Chin,Bruno Clément,Enrique de Alava,Françoise Degos,Martin L. Ferguson,Peter Geary,D. Neil Hayes,Amber L. Johns,Arek Kasprzyk,Hidewaki Nakagawa,Robert Penny,Miguel A. Piris,Rajiv Sarin,Aldo Scarpa,Marc J. van de Vijver,Marc J. van de Vijver,P. Andrew Futreal,Hiroyuki Aburatani,Mònica Bayés,David D.L. Bowtell,David D.L. Bowtell,Peter J. Campbel,Peter J. Campbel,Xavier Estivill,Sean M. Grimmond,Ivo Gut,Martin Hirst,Carlos López-Otý́n,Partha P. Majumder,Marco A. Marra,John Douglas Mcpherson,John Douglas Mcpherson,Zemin Ning,Xose S. Puente,Yijun Ruan,Hendrik G. Stunnenberg,Harold Swerdlow,Victor E. Velculescu,Richard K. Wilson,Hong Xue,Liu Yang,Paul T. Spellman,Gary D. Bader,Paul C. Boutros,Paul Flicek,Gad Getz,Roderic Guigó,Guangwu Guo,David Haussler,Simon Heath,Tim Hubbard,Tao Jiang,Steven J. M. Jones,Qibin Li,Nuria Lopez-Bigas,Ruibang Luo,Lakshmi Muthuswamy,B. F. Francis Ouellette,John V. Pearson,Víctor Quesada,Benjamin J. Raphael,Chris Sander,Terence P. Speed,Terence P. Speed,Lincoln Stein,Joshua M. Stuart,Jon W. Teague,Yasushi Totoki,Tatsuhiko Tsunoda,Alfonso Valencia,David A. Wheeler,Honglong Wu,Shancen Zhao,Guangyu Zhou,Mark Lathrop,Gilles Thomas,Teruhiko Yoshida,Myles Axton,Chris Gunter,Linda Miller,Junjun Zhang,Syed Haider,Jianxin Wang,Christina K. Yung,Anthony Cross,Yong Liang,Saravanamuttu Gnaneshan,Jonathan M. Guberman,Jack Hsu,Don Chalmers,Karl W. Hasel,Terry Sheung-Hung Kaan,William W. Lowrance,Tohru Masui,Laura Lyman Rodriguez,Catherine Vergely,David D.L. Bowtel,Nicole Cloonan,Anna deFazio,Anna deFazio,James R. Eshleman,Dariush Etemadmoghadam,Dariush Etemadmoghadam,Brooke A. Gardiner,James G. Kench,James G. Kench,Robert L. Sutherland,Margaret A. Tempero,Nicola Waddell,Peter Wilson,Steve Gallinger,Steve Gallinger,Ming-Sound Tsao,Ming-Sound Tsao,Patricia Shaw,Gloria M. Petersen,Debabrata Mukhopadhyay,Ronald A. DePinho,Sarah P. Thayer,Kamran Shazand,Timothy Beck,Michelle Sam,Lee Timms,Vanessa Ballin,Jiafu Ji,Xiuqing Zhang,Feng Chen,Xueda Hu,Qi Yang,Geng Tian,Lianhai Zhang,Xiaofang Xing,Xianghong Li,Zhenggang Zhu,Yingyan Yu,Jun Yu,Jörg Tost,Paul Brennan,Ivana Holcatova,David Zaridze,Alvis Brazma,Lars Egevad,Egor Prokhortchouk,Rosamonde E. Banks,Mathias Uhlén,Juris Viksna,Fredrik Pontén,Konstantin G. Skryabin,P. Andrew Futrea,Ewan Birney,Åke Borg,Anne Lise Børresen-Dale,Carlos Caldas,John A. Foekens,Sancha Martin,Jorge S. Reis-Filho,Andrea L. Richardson,Christos Sotiriou,Laura van 't Veer,Daniel Birnbaum,Hélène Blanché,Pascal Boucher,Sandrine Boyault,Jocelyne D. Masson-Jacquemier,Iris Pauporté,Xavier Pivot,Anne Vincent-Salomon,Eric Tabone,Charles Theillet,Isabelle Treilleux,Paulette Bioulac-Sage,Thomas Decaens,Franc OiseDegos,Dominique Franco,Gut M,Didier Samuel,Jessica Zucman-Rossi,Roland Eils,Roland Eils,Benedikt Brors,Jan O. Korbe,Andrey Korshunov,Pablo Landgraf,Hans Lehrach,Stefan M. Pfister,Stefan M. Pfister,Bernhard Radlwimmer,Guido Reifenberger,Michael D. Taylor,Christof von Kalle,Partha P. Majumder,Paolo Pederzoli,Rita T. Lawlor,Massimo Delledonne,Alberto Bardelli,Thomas M. Gress,David S. Klimstra,Giuseppe Zamboni,Yusuke Nakamura,Satoru Miyano,Akihiro Fujimoto,Elias Campo,Silvia de Sanjosé,Emili Montserrat,Marcos González-Dý́az,Pedro Jares,Heinz Himmelbaue,Sílvia Beà,Samuel Aparicio,Douglas F. Easton,Francis S. Collins,Carolyn C. Compton,Eric S. Lander,Wylie Burke,Anthony R. Green,Stanley R. Hamilton,Olli Kallioniemi,Timothy J. Ley,Edison T. Liu,Brandon J. Wainwright +273 more
- 15 Apr 2010
TL;DR: Systematic studies of more than 25,000 cancer genomes will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin,Andrew V. Biankin,Andrew V. Biankin,Nicola Waddell,Karin S. Kassahn,Marie-Claude Gingras,Lakshmi Muthuswamy,Amber L. Johns,David Miller,Peter Wilson,Ann-Marie Patch,Jianmin Wu,David K. Chang,David K. Chang,David K. Chang,Mark J. Cowley,Brooke Gardiner,Sarah Song,Ivon Harliwong,Senel Idrisoglu,Craig Nourse,Ehsan Nourbakhsh,Suzanne Manning,Shivangi Wani,Milena Gongora,Marina Pajic,Christopher J. Scarlett,Christopher J. Scarlett,Anthony J. Gill,Anthony J. Gill,Anthony J. Gill,Andreia V. Pinho,Ilse Rooman,Matthew J. Anderson,Oliver Holmes,Conrad Leonard,Darrin Taylor,Scott Wood,Qinying Xu,Katia Nones,J. Lynn Fink,Angelika N. Christ,Timothy J. C. Bruxner,Nicole Cloonan,Gabriel Kolle,Felicity Newell,Mark Pinese,R. Scott Mead,R. Scott Mead,Jeremy L. Humphris,Warren Kaplan,Marc D. Jones,Emily K. Colvin,Adnan Nagrial,Emily S. Humphrey,Angela Chou,Angela Chou,Venessa T. Chin,Lorraine A. Chantrill,Amanda Mawson,Jaswinder S. Samra,James G. Kench,James G. Kench,James G. Kench,Jessica A. Lovell,Roger J. Daly,Neil D. Merrett,Neil D. Merrett,Christopher W. Toon,Krishna Epari,Nam Q. Nguyen,Andrew Barbour,Nikolajs Zeps,Nipun Kakkar,Fengmei Zhao,Yuan Qing Wu,Min Wang,Donna M. Muzny,William E. Fisher,F. Charles Brunicardi,Sally E. Hodges,Jeffrey G. Reid,Jennifer Drummond,Kyle Chang,Yi Han,Lora Lewis,Huyen Dinh,Christian J. Buhay,Timothy Beck,Lee Timms,Michelle Sam,Kimberly Begley,Andrew M.K. Brown,Deepa Pai,Ami Panchal,Nicholas Buchner,Richard de Borja,Robert E. Denroche,Christina K. Yung,Stefano Serra,Nicole Onetto,Debabrata Mukhopadhyay,Ming-Sound Tsao,Patricia Shaw,Gloria M. Petersen,Steven Gallinger,Steven Gallinger,Ralph H. Hruban,Anirban Maitra,Christine A. Iacobuzio-Donahue,Richard D. Schulick,Christopher L. Wolfgang,Richard A. Morgan,Rita T. Lawlor,Paola Capelli,Vincenzo Corbo,Maria Scardoni,Giampaolo Tortora,Margaret A. Tempero,Karen M. Mann,Nancy A. Jenkins,Pedro A. Perez-Mancera,David J. Adams,David A. Largaespada,Lodewyk F. A. Wessels,Alistair G. Rust,Lincoln Stein,David A. Tuveson,Neal G. Copeland,Elizabeth A. Musgrove,Elizabeth A. Musgrove,Aldo Scarpa,James R. Eshleman,Thomas J. Hudson,Robert L. Sutherland,Robert L. Sutherland,David A. Wheeler,John V. Pearson,John Douglas Mcpherson,Richard A. Gibbs,Sean M. Grimmond +140 more
TL;DR: It is found that frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, are also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement ofAxon guidance genes in pancreatic carcinogenesis.
2.1K
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.
Charles Catzavelos,Nandita Bhattacharya,Yee C. Ung,James A. Wilson,Luba Roncari,Charanjit Sandhu,Patricia Shaw,Herman Yeger,Isabella Morava-Protzner,Linda Kapusta,Edmee Franssen,Kathleen I. Pritchard,Joyce M. Slingerland +12 more
TL;DR: It is demonstrated by immunohistochemistry that p27Kip1 protein levels are reduced in primary breast cancers and that this is associated with tumor progression in both in situ and invasive lesions, and shown to be regulated posttranscriptionally by in situ hybridization.
877
Cancer classification using the Immunoscore: a worldwide task force
Jérôme Galon,Franck Pagès,Francesco M. Marincola,Francesco M. Marincola,Helen K. Angell,Helen K. Angell,Magdalena Thurin,Alessandro Lugli,Inti Zlobec,Anne Berger,Carlo Bifulco,Gerardo Botti,Fabiana Tatangelo,Cedrik M. Britten,Sebastian Kreiter,Lotfi Chouchane,Paolo Delrio,Hartmann Arndt,Martin Asslaber,Michele Maio,Giuseppe Masucci,Martin C. Mihm,Fernando Vidal-Vanaclocha,James P. Allison,Sacha Gnjatic,Leif Håkansson,Christoph Huber,Harpreet Singh-Jasuja,Christian H. Ottensmeier,Heinz Zwierzina,Luigi Laghi,Fabio Grizzi,Pamela S. Ohashi,Patricia Shaw,Blaise Clarke,Bradly G. Wouters,Yutaka Kawakami,Shoichi Hazama,Kiyotaka Okuno,Ena Wang,Jill O'Donnell-Tormey,Christine Lagorce,Graham Pawelec,Michael I. Nishimura,Robert E. Hawkins,Réjean Lapointe,Andreas Lundqvist,Samir N. Khleif,Shuji Ogino,Peter Gibbs,Paul Waring,Noriyuki Sato,Toshihiko Torigoe,Kyogo Itoh,P. Patel,Shilin N. Shukla,Richard Palmqvist,Iris D. Nagtegaal,Yili Wang,Corrado D'Arrigo,Scott Kopetz,Frank A. Sinicrope,Giorgio Trinchieri,Thomas F. Gajewski,Thomas F. Gajewski,Paolo A. Ascierto,Bernard A. Fox,Bernard A. Fox,Bernard A. Fox +68 more
TL;DR: Evidence supports the notion to include immunological biomarkers, implemented as a tool for the prediction of prognosis and response to therapy, into traditional classification of cancer, designated TNM-I (TNM-Immune), and introduction of this parameter as a biomarker to classify cancers will facilitate clinical decision-making.
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
Harvey A. Risch,John R. McLaughlin,David E. C. Cole,Barry P. Rosen,Linda A. Bradley,Isabel Fan,James Tang,Song Li,Shiyu Zhang,Patricia Shaw,Steven A. Narod +10 more
TL;DR: BRCA1 and BRCA2 mutations may be more frequent in general populations than previously thought and may be associated with various types of cancers.